Last reviewed · How we verify
Diflucan®
At a glance
| Generic name | Diflucan® |
|---|---|
| Also known as | Reference Product |
| Sponsor | Pharmtechnology LLC |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Safety and Efficacy of Intralesional 0.5% Triamcinolone Acetonide in 0.2% Fluconazole Solution vs 0.1% Topical Mometasone Furoate With 2% Miconazole Nitrate Cream in the Treatment of Chronic Paronychia: An Intraindividual Randomized Controlled Trial. (PHASE3)
- PTX3-targeted Antifungal Prophylaxis (NA)
- Single Dose Crossover Comparative Bioavailability Study of Two Formulations of Fluconazole 200 mg in Healthy Adult Subjects Under Fasting Conditions (PHASE1)
- An Study to Evaluate the Effects of Fluconazole on the Pharmacokinetics (PK) of Sativex® in Healthy Subjects With Cannabis Experience. (PHASE1)
- Effects of Therapy With Sulfamylon® 5% Topical Solution Compared to a Historical Control Group (PHASE4)
- Fluconazol Versus Medical Honey in the Treatment of Recurrent Vulvovaginal Candidiasis (PHASE4)
- Bioavailability of Flucanazole (EARLY_PHASE1)
- Study to Collect Sera for Immunogenicity Testing in Children Vaccinated With Fluzone® (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Diflucan® CI brief — competitive landscape report
- Diflucan® updates RSS · CI watch RSS
- Pharmtechnology LLC portfolio CI